What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?

被引:4
|
作者
Wells, Katharine M. [1 ]
Boyd, Matthew J. [1 ]
Thornley, Tracey [2 ]
Boardman, Helen F. [1 ]
机构
[1] Univ Nottingham, Sch Pharm, Nottingham, England
[2] Boots UK, Nottingham, England
关键词
New Medicine Service; England; Prescription items; Pharmacy; MANAGEMENT; ATTITUDES;
D O I
10.1186/1472-6963-14-115
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service. This assumption is based on a theoretical calculation. This study aimed to find out the actual proportion of prescription items eligible for the NMS dispensed in community pharmacies in order to compare this with the theoretical assumption. The study also aimed to investigate whether the proportion of prescription items eligible for the NMS is affected by pharmacies' proximity to GP practices. Methods: The study collected data from eight pharmacies in Nottingham belonging to the same large chain of pharmacies. Pharmacies were grouped by distance from the nearest GP practice and sampled to reflect the distribution by distance of all pharmacies in Nottingham. Data on one thousand consecutive prescription items were collected from each pharmacy and the number of NMS eligible items recorded. All NHS prescriptions were included in the sample. Data were analysed and proportions calculated with 95% confidence intervals used to compare the study results against the theoretical figure of 0.5% of prescription items being eligible for the NMS. Results: A total of 8005 prescription items were collected (a minimum of 1000 items per pharmacy) of which 17 items were eligible to receive the service. The study found that 0.25% (95% confidence intervals: 0.14% to 0.36%) of prescription items were eligible for the NMS which differs significantly from the theoretical assumption of 0.5%. The opportunity rate for the service was lower, 0.21% (95% confidence intervals: 0.10% to 0.32%) of items, as some items eligible for the NMS did not translate into opportunities to offer the service. Of all the prescription items collected in the pharmacies, 28% were collected by patient representatives. Conclusions: The results of this study show that the proportion of items eligible for the NMS dispensed in community pharmacies is lower than the Department of Health assumption of 0.5%. This study did not find a significant difference in the rate of NMS opportunities between pharmacies located close to GP practices compared to those further away.
引用
收藏
页数:6
相关论文
共 45 条
  • [21] Herbal medicine usage in New Zealand: a pilot study focusing on customers of community pharmacies
    Beresford, RA
    Salls, ER
    Simpson, BH
    DRUG SAFETY, 2006, 29 (04) : 360 - 360
  • [22] Patients' perception toward the service quality of community pharmacies for no-prescription medicines during the COVID-19 pandemic
    Wongvedvanij, Ramida
    Darawong, Chonlatis
    INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 2023, 16 (03) : 378 - 384
  • [23] Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium
    Fraeyman, Jessica
    Foulon, Veerle
    Mehuys, Els
    Boussery, Koen
    Saevels, Jan
    De Vriese, Carine
    Dalleur, Olivia
    Housiaux, Marie
    Steurbaut, Stephane
    Naegels, Marc
    De Meyer, Guido R. Y.
    De Loof, Hans
    Van Hal, Guido
    Van den Broucke, Stephan
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (01): : 98 - 108
  • [24] netCare, a new collaborative primary health care service based in Swiss community pharmacies
    Erni, Pina
    von Overbeck, Jan
    Reich, Oliver
    Ruggli, Martine
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2016, 12 (04): : 622 - 626
  • [25] Professional services in Norwegian community pharmacies, with focus on a possible new service for patients with migraine
    Krogstad, T.
    Hanssen, L. M. Vhile
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 325 - 326
  • [26] Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service
    Elliott, Rachel Ann
    Boyd, Matthew J.
    Salema, Nde-Eshimuni
    Davies, James
    Barber, Nicholas
    Mehta, Rajnikant Laxmishanker
    Tanajewski, Lukasz
    Waring, Justin
    Latif, Asam
    Gkountouras, Georgios
    Avery, A. J.
    Chuter, Antony
    Craig, Christopher
    BMJ QUALITY & SAFETY, 2016, 25 (10) : 747 - 758
  • [27] What's New in Academic Medicine? Retained surgical items: Is "zero incidence" achievable?
    Nguyen, Michelle C.
    Moffatt-Bruce, Susan D.
    INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE, 2016, 2 (01) : 1 - 4
  • [28] Identifying risk for type 2 diabetes through Spanish community pharmacies: a new pharmacist service
    Molinero, Ana
    Fornos, Jose A.
    Andres, Nicanor F.
    Gomez, Fernando
    Soriano, Trinidad
    Sanchez, Ignacio
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (02) : 492 - 492
  • [29] P59 Know Your Vascular Age: A Feasibility Study on a New Service in Community Pharmacies
    Sofia Maximiano
    Patrícia Soares
    Mariana Rosa
    Ana Pinto
    Maria Mendes
    Joana Brito
    Sonja Gose
    Johannes Risse
    Telmo Pereira
    João Maldonado
    Ema Paulino
    Artery Research, 2018, 24 (1) : 95 - 96
  • [30] Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice
    Rachel A. Elliott
    Lukasz Tanajewski
    Georgios Gkountouras
    Anthony J. Avery
    Nick Barber
    Rajnikant Mehta
    Matthew J. Boyd
    Asam Latif
    Antony Chuter
    Justin Waring
    PharmacoEconomics, 2017, 35 : 1237 - 1255